Pros
No merger is going to be perfect, but given the size, complexity and time crunch it has gone pretty well. I doubt many of the reviewers complaining about the merger have any real business knowledge and/or have been part of a merger of this size/complexity in any substantial way. We bounced some deadweight (long overdue), got a more focused approach on the roadmap, are more transparent from EVP down to individual contributor, and are looking forwards and upwards.
Cons
From an R&D perspective it seems like some areas of Genesys R&D is a bit stuck in the 90s (architecture, technology choices, lack of true DevOps, waterfall as opposed to Agile development, heavy process, desire to hire resources in the cheapest regions). A significant portion of the innovation has come from M&As instead of internally. As more of a 'start-up' side of R&D we have to fight for every resource and just had to go through a small RIF - this all while other R&D groups are trying to hire a significant number of resources and appear to have competing strategies/products. This indicates a lack of shared vision and communication at the top-level of the organization. Two, or three depending on how you count it, R&D groups competing to deliver where the 'fight' is heavily stacked in one group's favor.